These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 20848524)
1. Association of FcgR2a, but not FcgR3a, with inflammatory bowel diseases across three Caucasian populations. Weersma RK; Crusius JB; Roberts RL; Koeleman BP; Palomino-Morales R; Wolfkamp S; Hollis-Moffatt JE; Festen EA; Meisneris S; Heijmans R; Noble CL; Gearry RB; Barclay ML; Gómez-Garcia M; Lopez-Nevot MA; Nieto A; Rodrigo L; Radstake TR; van Bodegraven AA; Wijmenga C; Merriman TR; Stokkers PC; Peña AS; Martín J; Alizadeh BZ Inflamm Bowel Dis; 2010 Dec; 16(12):2080-9. PubMed ID: 20848524 [TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis. Falvey JD; Bentley RW; Merriman TR; Hampton MB; Barclay ML; Gearry RB; Roberts RL World J Gastroenterol; 2013 Oct; 19(39):6656-64. PubMed ID: 24151396 [TBL] [Abstract][Full Text] [Related]
3. Independent replication of an association of CNVR7113.6 with Crohn's disease in Caucasians. Roberts RL; Diaz-Gallo LM; Barclay ML; Gómez-García M; Cardeña C; Merriman TR; Gearry RB; Martin J Inflamm Bowel Dis; 2012 Feb; 18(2):305-11. PubMed ID: 21560206 [TBL] [Abstract][Full Text] [Related]
4. Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B. Morgan AW; Barrett JH; Griffiths B; Subramanian D; Robinson JI; Keyte VH; Ali M; Jones EA; Old RW; Ponchel F; Boylston AW; Situnayake RD; Markham AF; Emery P; Isaacs JD Arthritis Res Ther; 2006; 8(1):R5. PubMed ID: 16356189 [TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population. Ferguson LR; Browning BL; Huebner C; Petermann I; Shelling AN; Demmers P; McCulloch A; Gearry RB; Barclay ML; Philpott M Dig Liver Dis; 2008 Sep; 40(9):723-30. PubMed ID: 18394979 [TBL] [Abstract][Full Text] [Related]
6. Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians. Mahurkar S; Banerjee R; Rani VS; Thakur N; Rao GV; Reddy DN; Chandak GR J Gastroenterol Hepatol; 2011 Apr; 26(4):694-9. PubMed ID: 21155887 [TBL] [Abstract][Full Text] [Related]
7. Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis. Morgan AW; Robinson JI; Barrett JH; Martin J; Walker A; Babbage SJ; Ollier WE; Gonzalez-Gay MA; Isaacs JD Arthritis Res Ther; 2006; 8(4):R109. PubMed ID: 16846526 [TBL] [Abstract][Full Text] [Related]
8. Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis. Alizadeh BZ; Valdigem G; Coenen MJ; Zhernakova A; Franke B; Monsuur A; van Riel PL; Barrera P; Radstake TR; Roep BO; Wijmenga C; Koeleman BP Hum Mol Genet; 2007 Nov; 16(21):2552-9. PubMed ID: 17652100 [TBL] [Abstract][Full Text] [Related]
9. Association of FCGR2A rs1801274 polymorphism with susceptibility to autoimmune diseases: A meta-analysis. Zhang C; Wang W; Zhang H; Wei L; Guo S Oncotarget; 2016 Jun; 7(26):39436-39443. PubMed ID: 27270653 [TBL] [Abstract][Full Text] [Related]
10. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands. Weersma RK; Zhernakova A; Nolte IM; Lefebvre C; Rioux JD; Mulder F; van Dullemen HM; Kleibeuker JH; Wijmenga C; Dijkstra G Am J Gastroenterol; 2008 Mar; 103(3):621-7. PubMed ID: 18047540 [TBL] [Abstract][Full Text] [Related]
11. A Case-Control Study on Association of Ulcerative Colitis with FCGR2A Gene Polymorphisms in Chinese Patients. Xia SL; Lin DP; Lin QR; Sun L; Wang XQ; Hong WJ; Lin ZJ; Du CC; Jiang Y Genet Test Mol Biomarkers; 2018 Oct; 22(10):607-614. PubMed ID: 30260678 [TBL] [Abstract][Full Text] [Related]
12. Genetic characteristics of inflammatory bowel disease in a Japanese population. Fuyuno Y; Yamazaki K; Takahashi A; Esaki M; Kawaguchi T; Takazoe M; Matsumoto T; Matsui T; Tanaka H; Motoya S; Suzuki Y; Kiyohara Y; Kitazono T; Kubo M J Gastroenterol; 2016 Jul; 51(7):672-81. PubMed ID: 26511940 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the sodium-dependent ascorbate transporter gene SLC23A1 are associated with susceptibility to Crohn disease. Amir Shaghaghi M; Bernstein CN; Serrano León A; El-Gabalawy H; Eck P Am J Clin Nutr; 2014 Feb; 99(2):378-83. PubMed ID: 24284447 [TBL] [Abstract][Full Text] [Related]
14. Impact of allele copy number of polymorphisms in FCGR3A and FCGR3B genes on susceptibility to ulcerative colitis. Asano K; Matsumoto T; Umeno J; Hirano A; Esaki M; Hosono N; Matsui T; Kiyohara Y; Nakamura Y; Kubo M; Kitazono T Inflamm Bowel Dis; 2013 Sep; 19(10):2061-8. PubMed ID: 23917248 [TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Brant SR; Okou DT; Simpson CL; Cutler DJ; Haritunians T; Bradfield JP; Chopra P; Prince J; Begum F; Kumar A; Huang C; Venkateswaran S; Datta LW; Wei Z; Thomas K; Herrinton LJ; Klapproth JA; Quiros AJ; Seminerio J; Liu Z; Alexander JS; Baldassano RN; Dudley-Brown S; Cross RK; Dassopoulos T; Denson LA; Dhere TA; Dryden GW; Hanson JS; Hou JK; Hussain SZ; Hyams JS; Isaacs KL; Kader H; Kappelman MD; Katz J; Kellermayer R; Kirschner BS; Kuemmerle JF; Kwon JH; Lazarev M; Li E; Mack D; Mannon P; Moulton DE; Newberry RD; Osuntokun BO; Patel AS; Saeed SA; Targan SR; Valentine JF; Wang MH; Zonca M; Rioux JD; Duerr RH; Silverberg MS; Cho JH; Hakonarson H; Zwick ME; McGovern DP; Kugathasan S Gastroenterology; 2017 Jan; 152(1):206-217.e2. PubMed ID: 27693347 [TBL] [Abstract][Full Text] [Related]
16. Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. Diaz-Gallo LM; Espino-Paisán L; Fransen K; Gómez-García M; van Sommeren S; Cardeña C; Rodrigo L; Mendoza JL; Taxonera C; Nieto A; Alcain G; Cueto I; López-Nevot MA; Bottini N; Barclay ML; Crusius JB; van Bodegraven AA; Wijmenga C; Ponsioen CY; Gearry RB; Roberts RL; Weersma RK; Urcelay E; Merriman TR; Alizadeh BZ; Martin J Inflamm Bowel Dis; 2011 Nov; 17(11):2287-94. PubMed ID: 21287672 [TBL] [Abstract][Full Text] [Related]
17. Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease. Shrestha UK; Karimi O; Crusius JB; Zhou F; Wang Z; Chen Z; van Bodegraven AA; Xiao J; Morré SA; Wang H; Li J; Xia B Inflamm Bowel Dis; 2010 Feb; 16(2):312-9. PubMed ID: 19714744 [TBL] [Abstract][Full Text] [Related]
18. TNFSF15 is an ethnic-specific IBD gene. Picornell Y; Mei L; Taylor K; Yang H; Targan SR; Rotter JI Inflamm Bowel Dis; 2007 Nov; 13(11):1333-8. PubMed ID: 17663424 [TBL] [Abstract][Full Text] [Related]
19. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease. Ebrahimi Daryani N; Sadr M; Soltani S; Saghazadeh A; Moossavi S; Shahkarami S; Farhadi E; Rezaei N Dig Dis; 2019; 37(1):21-32. PubMed ID: 30134230 [TBL] [Abstract][Full Text] [Related]
20. Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn's disease. Fiedler T; Büning C; Reuter W; Pitre G; Gentz E; Schmidt HH; Büttner J; Ockenga J; Gerloff T; Meisel C; Lochs H; Roots I; Köpke K; Johne A Eur J Clin Pharmacol; 2007 Oct; 63(10):917-25. PubMed ID: 17665184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]